EXCLUSIVE-Illumina remedies on Grail bid 'yet to convince' Eu antitrust regulators, sources say
3/3 17:52
U.S. life sciences company Illumina's offer to cut prices and allow rivals continued access to its technologies has 'yet to convince' EU antitrust regulators scrutinising its $8 billion cash-and-stock bid for Grail, people familiar with the matter said....